NewsBenzingaEikon Therapeutics 宣布 EIK1001 联合帕博利珠单抗和化疗用于一线 4 期非小细胞肺癌,显示与标准治疗联用具有持久疗效,且耐受性特征支持在门诊环境下进行全身给药 Eikon Therapeutics 宣布 EIK1001 联合帕博利珠单抗和化疗用于一线 4 期非小细胞肺癌,显示与标准治疗联用具有持久疗效,且耐受性特征支持在门诊环境下进行全身给药 Benzinga 2026.10.26 10:13 (GMT+0) Open on Benzinga Other news Marjorie Taylor Greene Says FAA Ground Stop, US Tech-Related Outages Began After GOP Midterm Setback: 'Chaos Keeps Everyone Distracted' ‘Give Every American Family a $1700 Check’: Ro Khanna Says Compensate American Families for Iran War Picard Medical Q3 Sales $200.000K Miss $1.550M Estimate 'That's Up to President Xi': Trump Hints at Kim Jong Un Meeting in China, and Crypto Punters Are Hiking Odds Aggressively ‘The Odds Are Almost Zero’: Scott Galloway Doesn’t See Jensen Huang Returning to Nvidia Jensen Huang at SpaceX? Elon Musk Calls It an ‘Honor’ as Crypto Bettors Price in the Odds
Marjorie Taylor Greene Says FAA Ground Stop, US Tech-Related Outages Began After GOP Midterm Setback: 'Chaos Keeps Everyone Distracted'
'That's Up to President Xi': Trump Hints at Kim Jong Un Meeting in China, and Crypto Punters Are Hiking Odds Aggressively